Extended Data Fig. 1. KiCS cohort characteristics.
(a) Distribution of tumor types (n = 303; 3 participants had two independent primary tumors. N = 186 for solid tumors, n = 67 for CNS tumors, n = 50 for leukemia/lymphomas). OTHER (Solid Tumors): ACC, AF, DCIS, DSRCT, EMC, EMS, ES, GCT, HCC, IDC, LB, LS, MAO, MFT, MM, MPNST, MRT, N, OF, PFHT, PGL, PT, RB, RCC, SBC, SCST, SN. OTHER (CNS Tumors): AM, CPC, CSRC, GG, GS, MN, MT, N, NE, SW. OTHER (Leukemia/Lymphoma): BPDCN, CML, LPD, MPAL. Please see Supplementary Table S1 for a full list of tumor types and acronyms. (b, c) Representative example of prior therapeutic exposures of sequenced samples (N = 232 tumor samples from 176 patients). (d) Age distribution (N = 300 participants). (e) Ethnicity distribution (based on self-reported ethnicity provided by 41% of study participants, N = 123 participants (59% missing data)).